Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders

Allen, 2007, Lipid raft microdomains and neurotransmitter signalling, Nat. Rev. Neurosci, 8, 128, 10.1038/nrn2059

Auerbach, 2011, Mutations causing syndromic autism define an axis of synaptic pathophysiology, Nature, 480, 63, 10.1038/nature10658

Baker, 2013, An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders, Cell, 152, 984, 10.1016/j.cell.2013.01.038

Bear, 2004, The mGluR theory of fragile X mental retardation, Trends Neurosci, 27, 370, 10.1016/j.tins.2004.04.009

Buchovecky, 2013, A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome, Nat. Genet, 45, 1013, 10.1038/ng.2714

Bukelis, 2007, Smith-Lemli-Opitz syndrome and autism spectrum disorder, Am. J. Psychiatry, 164, 1655, 10.1176/appi.ajp.2007.07020315

Delint-Ramirez, 2010, In vivo composition of NMDA receptor signaling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93, J. Neurosci, 30, 8162, 10.1523/JNEUROSCI.1792-10.2010

Delorme, 2013, Progress toward treatments for synaptic defects in autism, Nat. Med, 19, 685, 10.1038/nm.3193

Diaz-Stransky, 2012, Cognitive and behavioral aspects of Smith-Lemli-Opitz syndrome, Am. J. Med. Genet. C Semin. Med. Genet, 160C, 295, 10.1002/ajmg.c.31342

Dziobek, 2007, Hypercholesterolemia in Asperger syndrome: independence from lifestyle, obsessive-compulsive behavior, and social anxiety, Psychiatry Res, 149, 321, 10.1016/j.psychres.2006.02.003

Ebert, 2013, Activity-dependent neuronal signalling and autism spectrum disorder, Nature, 493, 327, 10.1038/nature11860

Fielding, 2004, Membrane cholesterol and the regulation of signal transduction, Biochem. Soc. Trans, 32, 65, 10.1042/BST0320065

Francesconi, 2009, Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar/lipid raft pathway, J. Neurosci, 29, 3590, 10.1523/JNEUROSCI.5824-08.2009

Hering, 2003, Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability, J. Neurosci, 23, 3262, 10.1523/JNEUROSCI.23-08-03262.2003

Huguet, 2013, The genetic landscapes of autism spectrum disorders, Annu. Rev. Genomics Hum. Genet, 14, 191, 10.1146/annurev-genom-091212-153431

Karasinska, 2011, Cholesterol metabolism in Huntington disease, Nat. Rev. Neurol, 7, 561, 10.1038/nrneurol.2011.132

Korade, 2008, Lipid rafts, cholesterol, and the brain, Neuropharmacology, 55, 1265, 10.1016/j.neuropharm.2008.02.019

Krumm, 2014, A de novo convergence of autism genetics and molecular neuroscience, Trends Neurosci, 37, 95, 10.1016/j.tins.2013.11.005

Kumari, 2013, Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains, J. Biol. Chem, 288, 32004, 10.1074/jbc.M113.475863

Lee, 2011, Hypothesis: the role of sterols in autism spectrum disorder, Autism Res. Treat, 2011, 653570, 10.1155/2011/653570

Levitan, 2010, Cholesterol and ion channels, Subcell. Biochem, 51, 509, 10.1007/978-90-481-8622-8_19

Li, 2005, The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1, Curr. Biol, 15, 1961, 10.1016/j.cub.2005.09.043

Linetti, 2010, Cholesterol reduction impairs exocytosis of synaptic vesicles, J. Cell Sci, 123, 595, 10.1242/jcs.060681

Lingwood, 2010, Lipid rafts as a membrane-organizing principle, Science, 327, 46, 10.1126/science.1174621

Liu, 2013, Specific interaction of postsynaptic densities with membrane rafts isolated from synaptic plasma membranes, J. Neurogenet, 27, 43, 10.3109/01677063.2013.772175

Lyst, 2013, Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor, Nat. Neurosci, 16, 898, 10.1038/nn.3434

Mathews, 2014, Mutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression, J. Neurosci, 34, 3402, 10.1523/JNEUROSCI.4587-13.2014

Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science, 294, 1354, 10.1126/science.294.5545.1354

Murdoch, 2013, Recent developments in the genetics of autism spectrum disorders, Curr. Opin. Genet. Dev, 23, 310, 10.1016/j.gde.2013.02.003

Nagy, 2013, Cholesterol metabolism and Rett syndrome pathogenesis, Nat. Genet, 45, 965, 10.1038/ng.2738

Osterweil, 2013, Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome, Neuron, 77, 243, 10.1016/j.neuron.2012.01.034

Pani, 2010, Cholesterol, Alzheimer's disease, prion disorders: a menage a trois?, Curr. Drug Targets, 11, 1018, 10.2174/138945010791591386

Persico, 2013, Autism genetics, Behav. Brain Res, 251, 95, 10.1016/j.bbr.2013.06.012

Pfrieger, 2003, Cholesterol homeostasis and function in neurons of the central nervous system, Cell. Mol. Life Sci, 60, 1158, 10.1007/s00018-003-3018-7

Pfrieger, 2011, Cholesterol metabolism in neurons and astrocytes, Prog. Lipid Res, 50, 357, 10.1016/j.plipres.2011.06.002

Pristera, 2011, Building excitable membranes: lipid rafts and multiple controls on trafficking of electrogenic molecules, Neuroscientist, 18, 70, 10.1177/1073858410393977

Ronemus, 2014, The role of de novo mutations in the genetics of autism spectrum disorders, Nat. Rev. Genet, 15, 133, 10.1038/nrg3585

Santoro, 2012, Molecular mechanisms of fragile X syndrome: a twenty-year perspective, Annu. Rev. Pathol, 7, 219, 10.1146/annurev-pathol-011811-132457

Schmunk, 2013, Channelopathy pathogenesis in autism spectrum disorders, Front. Genet, 4, 10.3389/fgene.2013.00222

Sebastiao, 2012, Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases, Neuropharmacology, 64, 97, 10.1016/j.neuropharm.2012.06.053

Sheng, 2007, The postsynaptic architecture of excitatory synapses: a more quantitative view, Annu. Rev. Biochem, 76, 823, 10.1146/annurev.biochem.76.060805.160029

Sheng, 2011, The postsynaptic organization of synapses, Cold Spring Harb. Perspect. Biol, 3, a005678, 10.1101/cshperspect.a005678

Sikora, 2006, The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome, Am. J. Med. Genet. A, 140, 1511, 10.1002/ajmg.a.31294

Simons, 2002, Cholesterol, lipid rafts, and disease, J. Clin. Invest, 110, 597, 10.1172/JCI0216390

Simons, 2011, Membrane organization and lipid rafts, Cold Spring Harb. Perspect. Biol, 3, a004697, 10.1101/cshperspect.a004697

Simons, 2000, Lipid rafts and signal transduction, Nat. Rev. Mol. Cell Biol, 1, 31, 10.1038/35036052

Suzuki, 2011, Association of membrane rafts and postsynaptic density: proteomics, biochemical, and ultrastructural analyses, J. Neurochem, 119, 64, 10.1111/j.1471-4159.2011.07404.x

Tierney, 2006, Abnormalities of cholesterol metabolism in autism spectrum disorders, Am. J. Med. Genet. B Neuropsychiatr. Genet, 141B, 666, 10.1002/ajmg.b.30368

Tsui-Pierchala, 2002, Lipid rafts in neuronal signaling and function, Trends Neurosci, 25, 412, 10.1016/S0166-2236(02)02215-4

van der Most, 2009, Statins: mechanisms of neuroprotection, Prog. Neurobiol, 88, 64, 10.1016/j.pneurobio.2009.02.002

Waage-Baudet, 2005, Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome, Dev. Neurosci, 27, 378, 10.1159/000088453

Wang, 2013, Reversing autism by targeting downstream mTOR signaling, Front. Cell. Neurosci, 7, 10.3389/fncel.2013.00028

Wang, 2010, Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization, J. Biol. Chem, 285, 21888, 10.1074/jbc.M110.116293

Wang, 2008b, FMRP acts as a key messenger for dopamine modulation in the forebrain, Neuron, 59, 634, 10.1016/j.neuron.2008.06.027

Wang, 2008a, Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors, J. Neurosci, 28, 4385, 10.1523/JNEUROSCI.0646-08.2008

Wang, 2012, Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases, Front. Pharmacol, 3, 10.3389/fphar.2012.00189

Wassif, 2001, Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith–Lemli–Opitz syndrome, Hum. Mol. Genet, 10, 555, 10.1093/hmg/10.6.555

Won, 2013, Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses, Front. Mol. Neurosci, 6, 10.3389/fnmol.2013.00019

Xu, 2013, A novel DNA-binding feature of MeCP2 contributes to Rett syndrome, Front. Cell. Neurosci, 7, 10.3389/fncel.2013.00064

Yaqoob, 2010, The nutritional and clinical significance of lipid rafts, Curr. Opin. Clin. Nutr. Metab. Care, 13, 156, 10.1097/MCO.0b013e328335725b

Zoghbi, 2012, Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities, Cold Spring Harb. Perspect. Biol, 4, a009886, 10.1101/cshperspect.a009886